Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHILD CARE: Ambroxol Hydrochloride Spray in Pediatric Acute Respiratory Infection
ChiCTR2200063661Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ambroxol in acute respiratory illness (ARI), cough and Mucus obstruction, sponsored by Beijing Children's Hospital. Primary endpoint: Change in cough symptom score. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
ambroxol
03
Conditions
acute respiratory illness (ARI)coughMucus obstruction
Beyond the preview
Go deeper on ChiCTR2200063661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063661.